John Libbey Eurotext

Environnement, Risques & Santé


Exposition à l’arsenic in utero : à la recherche de marqueurs épigénétiques d’intérêt Volume 16, issue 6, November-December 2017



This news is based on the following article: Kaushal A, Zhang H, Karmaus W, et al. Genome-wide methylation at birth in relation to in utero arsenic exposure and the associated health in later life. Environ Health 2017; 16: 50. doi: 10.1186/s12940-017-0262-0


In the field of developmental origins of health and disease, this exploratory study contributes to our understanding of the mechanisms linking in utero arsenic exposure to the later onset of disease. In particular it identifies five epigenetic biomarkers of exposure that may predict the risk of cardiovascular disease and diabetes.